Phase 0 Study of [18F]MNI-968 as a Marker for D1 Receptor in Healthy Subjects
NCT03082768
·
clinicaltrials.gov ↗
EARLY_PHASE1
Phase
COMPLETED
Status
6
Enrollment
OTHER
Sponsor class
Conditions
Healthy Volunteers
Interventions
DRUG:
[18F]MNI-968
Sponsor
Molecular NeuroImaging